{
  "symbol": "MRK",
  "year": 2024,
  "period": "Y2024",
  "curated_text": "Symbol: MRK. Year: 2024. Period: Y2024. ReportType: K10. Section: Competition and Market Position. This section discusses competitors, market dynamics, and regulatory landscape.  Competitors mentioned: the Health Care Environment Competition, Company, Health Care Environment and Government. Context excerpt: Competition and the Health Care Environment Competition The markets in which the Company conducts its business and the pharmaceutical industry in general are highly competitive and highly regulated. The Company\u2019s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, generic drug manufacturers, and animal health care companies. The Company\u2019s operations may be adversely affected by generic and biosimilar competition as the Company\u2019s products mature, as well as technological advances of competitors, industry consolidation, patents granted to competitors, competitive combination products, new products of competitors, the generic availability of competitors\u2019 branded products, and new information from clinical trials of marketed products or post-marketing surveillance. In addition, patent rights are increasingly being challenged by competitors, and the outcome can be highly uncertain. An adverse result in ",
  "competition_summary": [
    {
      "competitor": "the Health Care Environment Competition",
      "mentions": 1,
      "context": "Competition and the Health Care Environment Competition The markets in which the Company conducts its business and the pharmaceutical industry in general are highly competitive and highly regulated. The Company\u2019s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, generic drug manufacturers, and animal health care companies. The Company\u2019s operations may be adversely affected by generic and biosimilar competi"
    },
    {
      "competitor": "Company",
      "mentions": 3,
      "context": "Competition and the Health Care Environment Competition The markets in which the Company conducts its business and the pharmaceutical industry in general are highly competitive and highly regulated. The Company\u2019s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, generic drug manufacturers, and animal health care companies. The Company\u2019s operations may be adversely affected by generic and biosimilar competi"
    },
    {
      "competitor": "Health Care Environment and Government",
      "mentions": 1,
      "context": "Competition and the Health Care Environment Competition The markets in which the Company conducts its business and the pharmaceutical industry in general are highly competitive and highly regulated. The Company\u2019s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, generic drug manufacturers, and animal health care companies. The Company\u2019s operations may be adversely affected by generic and biosimilar competi"
    }
  ]
}